Pemphigus foliaceus induced by bucillamine [7]

European Journal of Dermatology

Volumn 17, Issue 1, 2007, Pages 98-99

  Fujita, Hideki ^a   Iguchi, Maho ^a   Watanabe, Rei ^b   Asahina, Akihiko ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCILLAMINE; CLOBETASOL PROPIONATE; DAPSONE; PENICILLAMINE; PREDNISOLONE;

CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; PEMPHIGUS; PEMPHIGUS FOLIACEUS; RHEUMATOID ARTHRITIS; SUBCORNEAL PUSTULAR DERMATOSIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYSTEINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS;

EID: 33847714659     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Horwitz LD. Bucillamine: a potent thiol donor with multiple clinical applications. Cardiovasc Drug Rev 2003; 21: 77-90.
2. Girgis L, Conaghan PG, Brooks P. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine. Curr Opin Rheumatol 1994; 6: 252-261.
3. Wolf R, Tamir A, Brenner S. Drug-induced versus drug-triggered pemphigus. Dermatologica 1991; 182: 182-207.
4. Brenner S, Wolf R, Ruocco V. Drug-induced pemphigus. I. A survey. Clin Dermatol 1993; 11: 501-5.
5. Kishimoto K, Iwatsuki K, Akiba H, Motoki Y, Kaneko F. Subcorneal pustular dermatosis-type IgA pemphigus induced by thiol drugs. Eur J Dermatol 2001; 11: 41-4.
6. Ogata K et al. Drug-induced pemphigus foliaceus with features of pempnigus vulgaris. Br J Dermatol 2001; 144: 421-2.